# PeptideScanner evidence objects: Ipamorelin

Every published version of the records placed with Ipamorelin, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json. Selected public evidence only; not medical advice.

- Objects: 17
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct00672074-ipamorelin-v1"></a>

## ClinicalTrials.gov record NCT00672074

> PeptideScanner retained ClinicalTrials.gov record NCT00672074 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-04-14, and PeptideScanner's reviewed identity mapping was ipamorelin.

- Evidence object: `story:clinicaltrials-gov-nct00672074-ipamorelin:v1`
- Evidence domain: Clinical trials
- Date in source: 2017-04-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00672074-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#clinicaltrials-gov-nct00672074-ipamorelin-v1
- Content SHA-256: `fee589088eb082218f11c4fbdce98b16c5ad009407360ec1926cb26771db6c41`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00672074 ([`ctg-observation-nct00672074-2017-04-14-09c53b030764`](#source-ctg-observation-nct00672074-2017-04-14-09c53b030764))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00672074 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-04-14, and PeptideScanner's reviewed identity mapping was ipamorelin. ([`ctg-observation-nct00672074-2017-04-14-09c53b030764`](#source-ctg-observation-nct00672074-2017-04-14-09c53b030764))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00672074 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-04-14, and PeptideScanner's reviewed identity mapping was ipamorelin. ([`ctg-observation-nct00672074-2017-04-14-09c53b030764`](#source-ctg-observation-nct00672074-2017-04-14-09c53b030764))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00672074-2017-04-14-09c53b030764`](#source-ctg-observation-nct00672074-2017-04-14-09c53b030764))

### Sources

<a id="source-ctg-observation-nct00672074-2017-04-14-09c53b030764"></a>
- **ClinicalTrials.gov record NCT00672074 · retained source version 2017-04-14:09c53b0307646dc9a23da8c7537ff9ca529da26aa628f0bcc0f160d5c7377750** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00672074) (`ctg-observation-nct00672074-2017-04-14-09c53b030764`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00672074." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#clinicaltrials-gov-nct00672074-ipamorelin-v1 SHA-256: fee589088eb082218f11c4fbdce98b16c5ad009407360ec1926cb26771db6c41.

---

<a id="clinicaltrials-gov-nct01280344-ipamorelin-v1"></a>

## ClinicalTrials.gov record NCT01280344

> PeptideScanner retained ClinicalTrials.gov record NCT01280344 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-04-13, and PeptideScanner's reviewed identity mapping was ipamorelin.

- Evidence object: `story:clinicaltrials-gov-nct01280344-ipamorelin:v1`
- Evidence domain: Clinical trials
- Date in source: 2017-04-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01280344-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#clinicaltrials-gov-nct01280344-ipamorelin-v1
- Content SHA-256: `3f166de0c640ac5a5da10b4d0f209b749ad4aa6e7c2bd7808bb50639c5e53d9a`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT01280344 ([`ctg-observation-nct01280344-2017-04-13-b15f25cff3ab`](#source-ctg-observation-nct01280344-2017-04-13-b15f25cff3ab))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01280344 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-04-13, and PeptideScanner's reviewed identity mapping was ipamorelin. ([`ctg-observation-nct01280344-2017-04-13-b15f25cff3ab`](#source-ctg-observation-nct01280344-2017-04-13-b15f25cff3ab))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01280344 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-04-13, and PeptideScanner's reviewed identity mapping was ipamorelin. ([`ctg-observation-nct01280344-2017-04-13-b15f25cff3ab`](#source-ctg-observation-nct01280344-2017-04-13-b15f25cff3ab))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01280344-2017-04-13-b15f25cff3ab`](#source-ctg-observation-nct01280344-2017-04-13-b15f25cff3ab))

### Sources

<a id="source-ctg-observation-nct01280344-2017-04-13-b15f25cff3ab"></a>
- **ClinicalTrials.gov record NCT01280344 · retained source version 2017-04-13:b15f25cff3ab9aa8068b28c9a9b3d653ded7938946cbc67600a4df6a130edc7e** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01280344) (`ctg-observation-nct01280344-2017-04-13-b15f25cff3ab`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01280344." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#clinicaltrials-gov-nct01280344-ipamorelin-v1 SHA-256: 3f166de0c640ac5a5da10b4d0f209b749ad4aa6e7c2bd7808bb50639c5e53d9a.

---

<a id="federal-register-2024-21241-v1"></a>

## Federal Register notice 2024-21241

> The Federal Register published notice 2024-21241, attributed to FDA and its parent HHS department, on 2024-09-18. Its official title is “Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List; Revisions to the Withdrawn or Removed List,” and PeptideScanner's exact reviewed identity mapping connects the document to Ipamorelin.

- Evidence object: `story:federal-register-2024-21241:v1`
- Evidence domain: Regulatory
- Date in source: 2024-09-18
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2024-21241/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#federal-register-2024-21241-v1
- Content SHA-256: `4a579035329ed042038c926655024640aaae66b9cf7a6879965ffd388dd83ae0`

### Claims and source pins

#### Headline

Federal Register notice 2024-21241 ([`federal-register-2024-21241-bbe8399c5872`](#source-federal-register-2024-21241-bbe8399c5872))

#### Summary

The Federal Register published notice 2024-21241, attributed to FDA and its parent HHS department, on 2024-09-18. Its official title is “Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List; Revisions to the Withdrawn or Removed List,” and PeptideScanner's exact reviewed identity mapping connects the document to Ipamorelin. ([`federal-register-2024-21241-bbe8399c5872`](#source-federal-register-2024-21241-bbe8399c5872))

#### Paragraph 1

The Federal Register published notice 2024-21241, attributed to FDA and its parent HHS department, on 2024-09-18. Its official title is “Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List; Revisions to the Withdrawn or Removed List,” and PeptideScanner's exact reviewed identity mapping connects the document to Ipamorelin. ([`federal-register-2024-21241-bbe8399c5872`](#source-federal-register-2024-21241-bbe8399c5872))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2024-21241-bbe8399c5872`](#source-federal-register-2024-21241-bbe8399c5872))

### Sources

<a id="source-federal-register-2024-21241-bbe8399c5872"></a>
- **Federal Register notice 2024-21241 · published 2024-09-18 · Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List; Revisions to the Withdrawn or Removed List** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2024-09-18/pdf/2024-21241.pdf) (`federal-register-2024-21241-bbe8399c5872`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 2024-21241." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#federal-register-2024-21241-v1 SHA-256: 4a579035329ed042038c926655024640aaae66b9cf7a6879965ffd388dd83ae0.

---

<a id="pubmed-pmid-10373343-ipamorelin-v1"></a>

## PubMed record PMID 10373343

> PeptideScanner retained PubMed bibliographic metadata for PMID 10373343 at 2026-07-30T22:15:26.481Z. PubMed recorded a metadata revision date of 2012-11-15 and an Entrez history date of 1999-06-22. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-10373343-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2012-11-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-10373343-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-10373343-ipamorelin-v1
- Content SHA-256: `862aeb9baeb86808499b3b849d74aba2f11b22b62f9ec94e305a5b10cb0b6c3b`

### Claims and source pins

#### Headline

PubMed record PMID 10373343 ([`pubmed-observation-pmid-10373343-2012-11-15-c7383374882f`](#source-pubmed-observation-pmid-10373343-2012-11-15-c7383374882f))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 10373343 at 2026-07-30T22:15:26.481Z. PubMed recorded a metadata revision date of 2012-11-15 and an Entrez history date of 1999-06-22. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-10373343-2012-11-15-c7383374882f`](#source-pubmed-observation-pmid-10373343-2012-11-15-c7383374882f))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 10373343 at 2026-07-30T22:15:26.481Z. PubMed recorded a metadata revision date of 2012-11-15 and an Entrez history date of 1999-06-22. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-10373343-2012-11-15-c7383374882f`](#source-pubmed-observation-pmid-10373343-2012-11-15-c7383374882f))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-10373343-2012-11-15-c7383374882f`](#source-pubmed-observation-pmid-10373343-2012-11-15-c7383374882f))

### Sources

<a id="source-pubmed-observation-pmid-10373343-2012-11-15-c7383374882f"></a>
- **PubMed record PMID 10373343 · retained source version 1:2012-11-15:current:c7383374882fe7e0e03895101dee3ed5f83971383629a9d06a0cd2fedd1b6395** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/10373343/) (`pubmed-observation-pmid-10373343-2012-11-15-c7383374882f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 10373343." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-10373343-ipamorelin-v1 SHA-256: 862aeb9baeb86808499b3b849d74aba2f11b22b62f9ec94e305a5b10cb0b6c3b.

---

<a id="pubmed-pmid-10496658-ipamorelin-v1"></a>

## PubMed record PMID 10496658

> PeptideScanner retained PubMed bibliographic metadata for PMID 10496658 at 2026-07-30T20:48:24.176Z. PubMed recorded a metadata revision date of 2019-08-18 and an Entrez history date of 1999-09-25. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-10496658-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-08-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-10496658-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-10496658-ipamorelin-v1
- Content SHA-256: `50ef4ae398c75848fc74c558e4f709e6b27388ea402280a536d062ac88433c34`

### Claims and source pins

#### Headline

PubMed record PMID 10496658 ([`pubmed-observation-pmid-10496658-2019-08-18-2e852a5a44c2`](#source-pubmed-observation-pmid-10496658-2019-08-18-2e852a5a44c2))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 10496658 at 2026-07-30T20:48:24.176Z. PubMed recorded a metadata revision date of 2019-08-18 and an Entrez history date of 1999-09-25. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-10496658-2019-08-18-2e852a5a44c2`](#source-pubmed-observation-pmid-10496658-2019-08-18-2e852a5a44c2))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 10496658 at 2026-07-30T20:48:24.176Z. PubMed recorded a metadata revision date of 2019-08-18 and an Entrez history date of 1999-09-25. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-10496658-2019-08-18-2e852a5a44c2`](#source-pubmed-observation-pmid-10496658-2019-08-18-2e852a5a44c2))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-10496658-2019-08-18-2e852a5a44c2`](#source-pubmed-observation-pmid-10496658-2019-08-18-2e852a5a44c2))

### Sources

<a id="source-pubmed-observation-pmid-10496658-2019-08-18-2e852a5a44c2"></a>
- **PubMed record PMID 10496658 · retained source version 1:2019-08-18:current:2e852a5a44c2cf078ee98f8fbf94ee090aa5c4d986b0b233e475478bb658555f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/10496658/) (`pubmed-observation-pmid-10496658-2019-08-18-2e852a5a44c2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 10496658." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-10496658-ipamorelin-v1 SHA-256: 50ef4ae398c75848fc74c558e4f709e6b27388ea402280a536d062ac88433c34.

---

<a id="pubmed-pmid-10828840-ipamorelin-v1"></a>

## PubMed record PMID 10828840

> PeptideScanner retained PubMed bibliographic metadata for PMID 10828840 at 2026-07-30T20:50:07.370Z. PubMed recorded a metadata revision date of 2019-07-09 and an Entrez history date of 2000-06-01. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-10828840-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-07-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-10828840-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-10828840-ipamorelin-v1
- Content SHA-256: `626f7165417a7aa88cf55eedd74b44f84def61a5c8b01fe25490c03b4832116c`

### Claims and source pins

#### Headline

PubMed record PMID 10828840 ([`pubmed-observation-pmid-10828840-2019-07-09-11730becbb77`](#source-pubmed-observation-pmid-10828840-2019-07-09-11730becbb77))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 10828840 at 2026-07-30T20:50:07.370Z. PubMed recorded a metadata revision date of 2019-07-09 and an Entrez history date of 2000-06-01. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-10828840-2019-07-09-11730becbb77`](#source-pubmed-observation-pmid-10828840-2019-07-09-11730becbb77))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 10828840 at 2026-07-30T20:50:07.370Z. PubMed recorded a metadata revision date of 2019-07-09 and an Entrez history date of 2000-06-01. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-10828840-2019-07-09-11730becbb77`](#source-pubmed-observation-pmid-10828840-2019-07-09-11730becbb77))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-10828840-2019-07-09-11730becbb77`](#source-pubmed-observation-pmid-10828840-2019-07-09-11730becbb77))

### Sources

<a id="source-pubmed-observation-pmid-10828840-2019-07-09-11730becbb77"></a>
- **PubMed record PMID 10828840 · retained source version 1:2019-07-09:current:11730becbb7778e455d2eeac357897b1242b8b3f5aa89d3a29803f43c3b132ec** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/10828840/) (`pubmed-observation-pmid-10828840-2019-07-09-11730becbb77`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 10828840." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-10828840-ipamorelin-v1 SHA-256: 626f7165417a7aa88cf55eedd74b44f84def61a5c8b01fe25490c03b4832116c.

---

<a id="pubmed-pmid-11459660-ipamorelin-v1"></a>

## PubMed record PMID 11459660

> PeptideScanner retained PubMed bibliographic metadata for PMID 11459660 at 2026-07-30T20:48:24.201Z. PubMed recorded a metadata revision date of 2019-08-19 and an Entrez history date of 2001-07-19. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-11459660-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-08-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-11459660-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-11459660-ipamorelin-v1
- Content SHA-256: `052c9c96d61b7d14e13b1fcbb15d5460923b9b79a8507b4d381a6c28b452a10b`

### Claims and source pins

#### Headline

PubMed record PMID 11459660 ([`pubmed-observation-pmid-11459660-2019-08-19-ed4aadeae3a2`](#source-pubmed-observation-pmid-11459660-2019-08-19-ed4aadeae3a2))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 11459660 at 2026-07-30T20:48:24.201Z. PubMed recorded a metadata revision date of 2019-08-19 and an Entrez history date of 2001-07-19. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-11459660-2019-08-19-ed4aadeae3a2`](#source-pubmed-observation-pmid-11459660-2019-08-19-ed4aadeae3a2))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 11459660 at 2026-07-30T20:48:24.201Z. PubMed recorded a metadata revision date of 2019-08-19 and an Entrez history date of 2001-07-19. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-11459660-2019-08-19-ed4aadeae3a2`](#source-pubmed-observation-pmid-11459660-2019-08-19-ed4aadeae3a2))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-11459660-2019-08-19-ed4aadeae3a2`](#source-pubmed-observation-pmid-11459660-2019-08-19-ed4aadeae3a2))

### Sources

<a id="source-pubmed-observation-pmid-11459660-2019-08-19-ed4aadeae3a2"></a>
- **PubMed record PMID 11459660 · retained source version 1:2019-08-19:current:ed4aadeae3a232d10f7351ca120efb595b5cdaf187da0e448b183dd59faf18a3** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/11459660/) (`pubmed-observation-pmid-11459660-2019-08-19-ed4aadeae3a2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 11459660." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-11459660-ipamorelin-v1 SHA-256: 052c9c96d61b7d14e13b1fcbb15d5460923b9b79a8507b4d381a6c28b452a10b.

---

<a id="pubmed-pmid-11735244-ipamorelin-v1"></a>

## PubMed record PMID 11735244

> PeptideScanner retained PubMed bibliographic metadata for PMID 11735244 at 2026-07-30T21:56:55.059Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2001-12-12. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-11735244-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-11735244-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-11735244-ipamorelin-v1
- Content SHA-256: `c1135b7f732b1252b77cb6af679c6e3ee378700062a65d640249d2dbb0d6774c`

### Claims and source pins

#### Headline

PubMed record PMID 11735244 ([`pubmed-observation-pmid-11735244-2013-11-21-efc086d0ae41`](#source-pubmed-observation-pmid-11735244-2013-11-21-efc086d0ae41))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 11735244 at 2026-07-30T21:56:55.059Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2001-12-12. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-11735244-2013-11-21-efc086d0ae41`](#source-pubmed-observation-pmid-11735244-2013-11-21-efc086d0ae41))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 11735244 at 2026-07-30T21:56:55.059Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2001-12-12. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-11735244-2013-11-21-efc086d0ae41`](#source-pubmed-observation-pmid-11735244-2013-11-21-efc086d0ae41))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-11735244-2013-11-21-efc086d0ae41`](#source-pubmed-observation-pmid-11735244-2013-11-21-efc086d0ae41))

### Sources

<a id="source-pubmed-observation-pmid-11735244-2013-11-21-efc086d0ae41"></a>
- **PubMed record PMID 11735244 · retained source version 1:2013-11-21:current:efc086d0ae41b6d3f3bbafbe8895bd793f0a19f18f16bdae0960a35445a71676** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/11735244/) (`pubmed-observation-pmid-11735244-2013-11-21-efc086d0ae41`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 11735244." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-11735244-ipamorelin-v1 SHA-256: c1135b7f732b1252b77cb6af679c6e3ee378700062a65d640249d2dbb0d6774c.

---

<a id="pubmed-pmid-12168778-ipamorelin-v1"></a>

## PubMed record PMID 12168778

> PeptideScanner retained PubMed bibliographic metadata for PMID 12168778 at 2026-07-30T21:25:18.666Z. PubMed recorded a metadata revision date of 2017-05-29 and an Entrez history date of 2002-08-10. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-12168778-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-05-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-12168778-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-12168778-ipamorelin-v1
- Content SHA-256: `9f11f22e95367ea872cfbe8cc0b05c3b4eafcc01709e21651c074c3d7465829d`

### Claims and source pins

#### Headline

PubMed record PMID 12168778 ([`pubmed-observation-pmid-12168778-2017-05-29-d75972d7db95`](#source-pubmed-observation-pmid-12168778-2017-05-29-d75972d7db95))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 12168778 at 2026-07-30T21:25:18.666Z. PubMed recorded a metadata revision date of 2017-05-29 and an Entrez history date of 2002-08-10. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-12168778-2017-05-29-d75972d7db95`](#source-pubmed-observation-pmid-12168778-2017-05-29-d75972d7db95))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 12168778 at 2026-07-30T21:25:18.666Z. PubMed recorded a metadata revision date of 2017-05-29 and an Entrez history date of 2002-08-10. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-12168778-2017-05-29-d75972d7db95`](#source-pubmed-observation-pmid-12168778-2017-05-29-d75972d7db95))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-12168778-2017-05-29-d75972d7db95`](#source-pubmed-observation-pmid-12168778-2017-05-29-d75972d7db95))

### Sources

<a id="source-pubmed-observation-pmid-12168778-2017-05-29-d75972d7db95"></a>
- **PubMed record PMID 12168778 · retained source version 1:2017-05-29:current:d75972d7db9581d3489d122f92b746bc3f5f5cb7d20b9c42ed842f67fbe2aa4d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/12168778/) (`pubmed-observation-pmid-12168778-2017-05-29-d75972d7db95`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 12168778." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-12168778-ipamorelin-v1 SHA-256: 9f11f22e95367ea872cfbe8cc0b05c3b4eafcc01709e21651c074c3d7465829d.

---

<a id="pubmed-pmid-15665799-ipamorelin-v1"></a>

## PubMed record PMID 15665799

> PeptideScanner retained PubMed bibliographic metadata for PMID 15665799 at 2026-07-30T21:09:05.701Z. PubMed recorded a metadata revision date of 2018-12-17 and an Entrez history date of 2005-01-25. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-15665799-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15665799-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-15665799-ipamorelin-v1
- Content SHA-256: `c6b16015752ec6f51b8931dcd24734355c92ab70bfa4e05fb579c44e7c742ddf`

### Claims and source pins

#### Headline

PubMed record PMID 15665799 ([`pubmed-observation-pmid-15665799-2018-12-17-4b33a305874b`](#source-pubmed-observation-pmid-15665799-2018-12-17-4b33a305874b))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 15665799 at 2026-07-30T21:09:05.701Z. PubMed recorded a metadata revision date of 2018-12-17 and an Entrez history date of 2005-01-25. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-15665799-2018-12-17-4b33a305874b`](#source-pubmed-observation-pmid-15665799-2018-12-17-4b33a305874b))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 15665799 at 2026-07-30T21:09:05.701Z. PubMed recorded a metadata revision date of 2018-12-17 and an Entrez history date of 2005-01-25. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-15665799-2018-12-17-4b33a305874b`](#source-pubmed-observation-pmid-15665799-2018-12-17-4b33a305874b))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15665799-2018-12-17-4b33a305874b`](#source-pubmed-observation-pmid-15665799-2018-12-17-4b33a305874b))

### Sources

<a id="source-pubmed-observation-pmid-15665799-2018-12-17-4b33a305874b"></a>
- **PubMed record PMID 15665799 · retained source version 1:2018-12-17:current:4b33a305874b553f78e3706fbb5ec31517d4fc8c0a95dce6ef0b8baa61736ca7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15665799/) (`pubmed-observation-pmid-15665799-2018-12-17-4b33a305874b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 15665799." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-15665799-ipamorelin-v1 SHA-256: c6b16015752ec6f51b8931dcd24734355c92ab70bfa4e05fb579c44e7c742ddf.

---

<a id="pubmed-pmid-25331030-ipamorelin-v1"></a>

## PubMed record PMID 25331030

> PeptideScanner retained PubMed bibliographic metadata for PMID 25331030 at 2026-07-30T16:20:34.456Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2014-10-22. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-25331030-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25331030-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-25331030-ipamorelin-v1
- Content SHA-256: `6b587a51af52d79c4e1a8c1134942ebdad341601772738fdafe599c147b23850`

### Claims and source pins

#### Headline

PubMed record PMID 25331030 ([`pubmed-observation-pmid-25331030-2026-05-18-6e0072f3c6d9`](#source-pubmed-observation-pmid-25331030-2026-05-18-6e0072f3c6d9))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 25331030 at 2026-07-30T16:20:34.456Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2014-10-22. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-25331030-2026-05-18-6e0072f3c6d9`](#source-pubmed-observation-pmid-25331030-2026-05-18-6e0072f3c6d9))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 25331030 at 2026-07-30T16:20:34.456Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2014-10-22. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-25331030-2026-05-18-6e0072f3c6d9`](#source-pubmed-observation-pmid-25331030-2026-05-18-6e0072f3c6d9))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25331030-2026-05-18-6e0072f3c6d9`](#source-pubmed-observation-pmid-25331030-2026-05-18-6e0072f3c6d9))

### Sources

<a id="source-pubmed-observation-pmid-25331030-2026-05-18-6e0072f3c6d9"></a>
- **PubMed record PMID 25331030 · retained source version 1:2026-05-18:current:6e0072f3c6d9c15aa9f7ac6dba38512256211c820d6cd46e601ab52334317168** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25331030/) (`pubmed-observation-pmid-25331030-2026-05-18-6e0072f3c6d9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 25331030." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-25331030-ipamorelin-v1 SHA-256: 6b587a51af52d79c4e1a8c1134942ebdad341601772738fdafe599c147b23850.

---

<a id="pubmed-pmid-25869809-ipamorelin-v1"></a>

## PubMed record PMID 25869809

> PeptideScanner retained PubMed bibliographic metadata for PMID 25869809 at 2026-07-30T20:43:08.964Z. PubMed recorded a metadata revision date of 2019-12-10 and an Entrez history date of 2015-04-15. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-25869809-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-12-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25869809-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-25869809-ipamorelin-v1
- Content SHA-256: `c2f1f65d8120bc2869a7f0424b924993b933b462d93223bf2d097ce79a8131c6`

### Claims and source pins

#### Headline

PubMed record PMID 25869809 ([`pubmed-observation-pmid-25869809-2019-12-10-2d3fce659d63`](#source-pubmed-observation-pmid-25869809-2019-12-10-2d3fce659d63))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 25869809 at 2026-07-30T20:43:08.964Z. PubMed recorded a metadata revision date of 2019-12-10 and an Entrez history date of 2015-04-15. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-25869809-2019-12-10-2d3fce659d63`](#source-pubmed-observation-pmid-25869809-2019-12-10-2d3fce659d63))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 25869809 at 2026-07-30T20:43:08.964Z. PubMed recorded a metadata revision date of 2019-12-10 and an Entrez history date of 2015-04-15. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-25869809-2019-12-10-2d3fce659d63`](#source-pubmed-observation-pmid-25869809-2019-12-10-2d3fce659d63))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25869809-2019-12-10-2d3fce659d63`](#source-pubmed-observation-pmid-25869809-2019-12-10-2d3fce659d63))

### Sources

<a id="source-pubmed-observation-pmid-25869809-2019-12-10-2d3fce659d63"></a>
- **PubMed record PMID 25869809 · retained source version 1:2019-12-10:current:2d3fce659d63bdaaaead473a79c073e5ef818c68eda03597b6a12327b2167384** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25869809/) (`pubmed-observation-pmid-25869809-2019-12-10-2d3fce659d63`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 25869809." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-25869809-ipamorelin-v1 SHA-256: c2f1f65d8120bc2869a7f0424b924993b933b462d93223bf2d097ce79a8131c6.

---

<a id="pubmed-pmid-38996787-ipamorelin-v1"></a>

## The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus.

> PubMed lists PMID 38996787 in Animal reproduction science as Journal Article, with publication-date metadata of 2024-07-05 (day precision). PeptideScanner associated the retained record with the identity slug ipamorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38996787-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-08-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38996787-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-38996787-ipamorelin-v1
- Content SHA-256: `1bb2c7787b91c0f21cf07b8a5edb2d65a2fda1237a7a20a50033ac8803274c8d`

### Claims and source pins

#### Headline

The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus. ([`pubmed-observation-pmid-38996787-2024-08-27-0dfdd718791c`](#source-pubmed-observation-pmid-38996787-2024-08-27-0dfdd718791c))

#### Summary

PubMed lists PMID 38996787 in Animal reproduction science as Journal Article, with publication-date metadata of 2024-07-05 (day precision). PeptideScanner associated the retained record with the identity slug ipamorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38996787-2024-08-27-0dfdd718791c`](#source-pubmed-observation-pmid-38996787-2024-08-27-0dfdd718791c))

#### Paragraph 1

PubMed lists PMID 38996787 in Animal reproduction science as Journal Article, with publication-date metadata of 2024-07-05 (day precision). PeptideScanner associated the retained record with the identity slug ipamorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38996787-2024-08-27-0dfdd718791c`](#source-pubmed-observation-pmid-38996787-2024-08-27-0dfdd718791c))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38996787-2024-08-27-0dfdd718791c`](#source-pubmed-observation-pmid-38996787-2024-08-27-0dfdd718791c))

### Sources

<a id="source-pubmed-observation-pmid-38996787-2024-08-27-0dfdd718791c"></a>
- **The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus. · retained source version 1:2024-08-27:current:0dfdd718791c353393bff8e2f5927162ff9285d69b931d00fe15c37189919c0d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38996787/) (`pubmed-observation-pmid-38996787-2024-08-27-0dfdd718791c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-38996787-ipamorelin-v1 SHA-256: 1bb2c7787b91c0f21cf07b8a5edb2d65a2fda1237a7a20a50033ac8803274c8d.

---

<a id="pubmed-pmid-39043357-ipamorelin-v1"></a>

## PubMed record PMID 39043357

> PeptideScanner retained PubMed bibliographic metadata for PMID 39043357 at 2026-07-30T16:20:38.933Z. PubMed recorded a metadata revision date of 2026-05-24 and an Entrez history date of 2024-07-23. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39043357-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-24
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39043357-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-39043357-ipamorelin-v1
- Content SHA-256: `8d80844681c64cf95649e883a6691d2d37d37cafdbd61e67d6e799b90a170f48`

### Claims and source pins

#### Headline

PubMed record PMID 39043357 ([`pubmed-observation-pmid-39043357-2026-05-24-8849c6f53748`](#source-pubmed-observation-pmid-39043357-2026-05-24-8849c6f53748))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39043357 at 2026-07-30T16:20:38.933Z. PubMed recorded a metadata revision date of 2026-05-24 and an Entrez history date of 2024-07-23. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39043357-2026-05-24-8849c6f53748`](#source-pubmed-observation-pmid-39043357-2026-05-24-8849c6f53748))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39043357 at 2026-07-30T16:20:38.933Z. PubMed recorded a metadata revision date of 2026-05-24 and an Entrez history date of 2024-07-23. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39043357-2026-05-24-8849c6f53748`](#source-pubmed-observation-pmid-39043357-2026-05-24-8849c6f53748))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39043357-2026-05-24-8849c6f53748`](#source-pubmed-observation-pmid-39043357-2026-05-24-8849c6f53748))

### Sources

<a id="source-pubmed-observation-pmid-39043357-2026-05-24-8849c6f53748"></a>
- **PubMed record PMID 39043357 · retained source version 1:2026-05-24:current:8849c6f53748331bc4b95b4f28e92aba0371cdaacbf289f9a6b64f0157a87ea8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39043357/) (`pubmed-observation-pmid-39043357-2026-05-24-8849c6f53748`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39043357." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-39043357-ipamorelin-v1 SHA-256: 8d80844681c64cf95649e883a6691d2d37d37cafdbd61e67d6e799b90a170f48.

---

<a id="pubmed-pmid-9733495-ipamorelin-v1"></a>

## PubMed record PMID 9733495

> PeptideScanner retained PubMed bibliographic metadata for PMID 9733495 at 2026-07-30T21:08:59.367Z. PubMed recorded a metadata revision date of 2018-12-01 and an Entrez history date of 1998-09-11. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-9733495-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9733495-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-9733495-ipamorelin-v1
- Content SHA-256: `daef84f204cdc3dd2ebae081e54b063a63ceaa2ca885b442daaa9cbe9ff99bc0`

### Claims and source pins

#### Headline

PubMed record PMID 9733495 ([`pubmed-observation-pmid-9733495-2018-12-01-436e0312b9b9`](#source-pubmed-observation-pmid-9733495-2018-12-01-436e0312b9b9))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 9733495 at 2026-07-30T21:08:59.367Z. PubMed recorded a metadata revision date of 2018-12-01 and an Entrez history date of 1998-09-11. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9733495-2018-12-01-436e0312b9b9`](#source-pubmed-observation-pmid-9733495-2018-12-01-436e0312b9b9))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 9733495 at 2026-07-30T21:08:59.367Z. PubMed recorded a metadata revision date of 2018-12-01 and an Entrez history date of 1998-09-11. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9733495-2018-12-01-436e0312b9b9`](#source-pubmed-observation-pmid-9733495-2018-12-01-436e0312b9b9))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9733495-2018-12-01-436e0312b9b9`](#source-pubmed-observation-pmid-9733495-2018-12-01-436e0312b9b9))

### Sources

<a id="source-pubmed-observation-pmid-9733495-2018-12-01-436e0312b9b9"></a>
- **PubMed record PMID 9733495 · retained source version 1:2018-12-01:current:436e0312b9b928f04e8d358c76e1610cbea9e3bb6fd862a2967bc1ebd7a13586** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9733495/) (`pubmed-observation-pmid-9733495-2018-12-01-436e0312b9b9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 9733495." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-9733495-ipamorelin-v1 SHA-256: daef84f204cdc3dd2ebae081e54b063a63ceaa2ca885b442daaa9cbe9ff99bc0.

---

<a id="pubmed-pmid-9849822-ipamorelin-v1"></a>

## PubMed record PMID 9849822

> PeptideScanner retained PubMed bibliographic metadata for PMID 9849822 at 2026-07-30T20:46:59.652Z. PubMed recorded a metadata revision date of 2019-09-05 and an Entrez history date of 1998-12-16. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-9849822-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-09-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9849822-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-9849822-ipamorelin-v1
- Content SHA-256: `7e77ec8038515ef3934f6aa68a593c8e788362cd4cc1f07c02aeb1f0aff1a0c8`

### Claims and source pins

#### Headline

PubMed record PMID 9849822 ([`pubmed-observation-pmid-9849822-2019-09-05-ead4784c1b36`](#source-pubmed-observation-pmid-9849822-2019-09-05-ead4784c1b36))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 9849822 at 2026-07-30T20:46:59.652Z. PubMed recorded a metadata revision date of 2019-09-05 and an Entrez history date of 1998-12-16. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9849822-2019-09-05-ead4784c1b36`](#source-pubmed-observation-pmid-9849822-2019-09-05-ead4784c1b36))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 9849822 at 2026-07-30T20:46:59.652Z. PubMed recorded a metadata revision date of 2019-09-05 and an Entrez history date of 1998-12-16. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9849822-2019-09-05-ead4784c1b36`](#source-pubmed-observation-pmid-9849822-2019-09-05-ead4784c1b36))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9849822-2019-09-05-ead4784c1b36`](#source-pubmed-observation-pmid-9849822-2019-09-05-ead4784c1b36))

### Sources

<a id="source-pubmed-observation-pmid-9849822-2019-09-05-ead4784c1b36"></a>
- **PubMed record PMID 9849822 · retained source version 1:2019-09-05:current:ead4784c1b363f6de4df69ca76a7fe5521372b0f431e1fb974c8a03a33f7443f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9849822/) (`pubmed-observation-pmid-9849822-2019-09-05-ead4784c1b36`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 9849822." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-9849822-ipamorelin-v1 SHA-256: 7e77ec8038515ef3934f6aa68a593c8e788362cd4cc1f07c02aeb1f0aff1a0c8.

---

<a id="pubmed-pmid-9879640-ipamorelin-v1"></a>

## PubMed record PMID 9879640

> PeptideScanner retained PubMed bibliographic metadata for PMID 9879640 at 2026-07-30T20:46:59.653Z. PubMed recorded a metadata revision date of 2019-09-09 and an Entrez history date of 1999-01-08. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-9879640-ipamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-09-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-9879640-ipamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-9879640-ipamorelin-v1
- Content SHA-256: `53c36b74bbad746ef42e1869aa8242746ea3aaa7d267443a804b00c274013f37`

### Claims and source pins

#### Headline

PubMed record PMID 9879640 ([`pubmed-observation-pmid-9879640-2019-09-09-5e20a17b8b69`](#source-pubmed-observation-pmid-9879640-2019-09-09-5e20a17b8b69))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 9879640 at 2026-07-30T20:46:59.653Z. PubMed recorded a metadata revision date of 2019-09-09 and an Entrez history date of 1999-01-08. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9879640-2019-09-09-5e20a17b8b69`](#source-pubmed-observation-pmid-9879640-2019-09-09-5e20a17b8b69))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 9879640 at 2026-07-30T20:46:59.653Z. PubMed recorded a metadata revision date of 2019-09-09 and an Entrez history date of 1999-01-08. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-9879640-2019-09-09-5e20a17b8b69`](#source-pubmed-observation-pmid-9879640-2019-09-09-5e20a17b8b69))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-9879640-2019-09-09-5e20a17b8b69`](#source-pubmed-observation-pmid-9879640-2019-09-09-5e20a17b8b69))

### Sources

<a id="source-pubmed-observation-pmid-9879640-2019-09-09-5e20a17b8b69"></a>
- **PubMed record PMID 9879640 · retained source version 1:2019-09-09:current:5e20a17b8b6994a900cd385440b34931ce5d70ffbb4424a0197b4ced604e1b15** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/9879640/) (`pubmed-observation-pmid-9879640-2019-09-09-5e20a17b8b69`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 9879640." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/ipamorelin.json#pubmed-pmid-9879640-ipamorelin-v1 SHA-256: 53c36b74bbad746ef42e1869aa8242746ea3aaa7d267443a804b00c274013f37.

